Enterprise League logo
SpringWorks Therapeutics Logo

SpringWorks Therapeutics

Stamford, United States (US) · Health and Medical

Do your work at SpringWorks Therapeutics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

SpringWorks Therapeutics is a US-based biopharmaceutical company of Merck KGaA, Darmstadt, Germany, dedicated to developing innovative treatments for patients with rare tumors.

We’ve achieved FDA and EC approval for the first and only medicines for adults with desmoid tumors and the first and only medicines for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN).

At SpringWorks, we’re driven by a commitment to finding answers for those facing rare diseases, fueled by a culture of urgency and tenacity. Our focus is on BCMA combinations in multiple myeloma and we are actively engaged in investigator-initiated research to unlock the full potential of targeted oncology.

We value authenticity and diversity, recognizing that a wide range of perspectives is essential to our mission of improving patient outcomes.

Most teams do this before shortlisting


Contact Details

info@springworkstx.com

Stamford, United States (US), 100 Washington Blvd

+1

Founded

2017

Company Type

Public Limited Company

Employees

200-500

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after SpringWorks Therapeutics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.